Michael Cloonan

Insider Reports History

Entity
Individual
Location
C/O Sage Therapeutics, Inc., 215 First Street, Cambridge, MA
Signature
/s/ Jennifer Fitzpatrick, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Cloonan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
bluebird bio, Inc. Director Common Stock 37.4K $19.6K $0.53 Sep 30, 2024 Direct
Sionna Therapeutics, Inc. President & CEO, Director Common Stock 547K Feb 6, 2025 Direct
Sionna Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 450K Feb 6, 2025 Direct
bluebird bio, Inc. Director Stock Option (right to buy) 74.8K Jun 20, 2024 Direct

Insider Reports Filed by Michael Cloonan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SION Sionna Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 President & CEO, Director
SION Sionna Therapeutics, Inc. Feb 6, 2025 0 $0 3 Feb 6, 2025 President & CEO, Director
BLUE bluebird bio, Inc. Sep 30, 2024 1 $0 4 Oct 2, 2024 Director
BLUE bluebird bio, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
BLUE bluebird bio, Inc. Jun 20, 2024 0 $0 3 Jun 24, 2024 Director